Clinical Trial Record

Return to Clinical Trials

Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling


2021-05-25


2023-06-28


2023-06-28


78

Study Overview

Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling

The purpose of this research study is to understand the impact of an educational video or pamphlet on the patient experience in a hereditary cancer genetic counseling program. In order to make this assessment, it is necessary to perform qualitative and quantitative research among patients in a hereditary cancer genetic counseling clinic.

N/A

  • Quality
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • OTHER: Educational video and pamphlet
  • OTHER: Traditional genetic counseling
  • IRB-61374
  • VAR0214 (OTHER Identifier) (OTHER: OnCore)
  • NCI-2022-00606 (OTHER Identifier) (OTHER: CTRP)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2021-10-25  

N/A  

2024-08-07  

2021-11-12  

N/A  

2024-08-09  

2021-11-24  

N/A  

2024-08  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Non Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: pre-educated with educational video

Participants will receive a message to view educational videos prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The video will be shared with patients via MyHealth in the "education" tab in advance of the genetic c

OTHER: Educational video and pamphlet

  • The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session

OTHER: Traditional genetic counseling

  • Patients will receive traditional genetic counseling
EXPERIMENTAL: pre-educated with pamphlet

Participants will receive a message to view a pamphlet prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The pamphlet will be sent to patients who cannot access the video via regular mail in advance of the genetic c

OTHER: Educational video and pamphlet

  • The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session

OTHER: Traditional genetic counseling

  • Patients will receive traditional genetic counseling
OTHER: educated during the session

Participants will receive traditional genetic counseling. . After the genetic counseling session, they will fill out a validated survey called the Multi-dimensional Measure of Informed Choice (MMIC) that assesses attitudes, knowledge, and uptake of geneti

OTHER: Traditional genetic counseling

  • Patients will receive traditional genetic counseling
Primary Outcome MeasuresMeasure DescriptionTime Frame
Patient impact with educational information prior to genetic counselingImpact will be defined as the number of questions asked by patient during the counseling.36 months
Patient impact without any educational information prior to genetic counselingImpact will be defined as the number of questions asked by patient during the counseling.36 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    Inclusion criteria for: Limited English Proficiency (LEP), primarily Spanish speaking cohort

  • Preferred language for receiving medical information is Spanish
  • Has a personal or family history of cancer
  • If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet

  • Inclusion criteria for: Individuals with a personal or family history of breast cancer cohort

  • Personal or family history of breast cancer
  • English is preferred language
  • If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet

  • Inclusion criteria for: Individuals with a personal or family history of prostate cancer cohort

  • Personal or family history of prostate cancer
  • English is preferred language
  • If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet

  • Inclusion criteria for: Individuals with a personal or family history of any type of cancer referred for germline testing based on a genetic variant identified during tumor genomic analysis for the patient or affected family member cohort.

  • Personal or family history of any type of cancer
  • Referred based on a variant identified during tumor genomic analysis
  • English is preferred language
  • If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet

  • Inclusion criteria for: Individuals with a personal or family history of gastrointestinal or gynecologic cancer, referred because they or their affected relative screened positive for Lynch Syndrome based on either an immunohistochemistry test or evidence of mismatch repair deficiency in their tumor cohort.

  • Personal or family history of gastrointestinal or gynecologic cancer
  • Screened positive for Lynch Syndrome based on IHC or MMR testing
  • English is preferred language
  • If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet

  • Inclusion criteria for: Individuals with a personal or family history of ovarian and/or pancreatic cancer cohort

  • Personal or family history of ovarian, and/or pancreatic cancer
  • English is preferred language
  • If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet

  • Exclusion Criteria:

  • Individuals who are minors
  • Individuals who are decisionally impaired

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: James Ford, MD, Stanford University

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available